Caption Management’s Halozyme HALO Stock Holding History

Caption Management’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-10,000	Closed	-$673K	–	1746
2025 Q4	$673K	Buy	+10,000	New	+$673K	﹤0.01%	1175
2021 Q2	–	Sell	-35,800	Closed	-$1.49M	–	1405
2021 Q1	$1.49M	Buy	+35,800	New	+$1.63M	0.03%	589
2020 Q2	–	Sell	-60,000	Closed	-$1.08M	–	1043
2020 Q1	$1.08M	Sell	60,000 -105,000	-64%	-$1.99M	0.06%	388
2019 Q4	$2.93M	Buy	165,000 +75,000	+83%	+$1.3M	0.1%	283
2019 Q3	$1.4M	Buy	+90,000	New	+$1.48M	0.07%	315
2018 Q4	–	Sell	-25,000	Closed	-$454K	–	524
2018 Q3	$454K	Buy	+25,000	New	+$438K	0.03%	419
2018 Q1	–	Sell	-522,200	Closed	-$10.6M	–	262
2017 Q4	$10.6M	Buy	+522,200	New	+$9.6M	1.1%	23

Other funds holding HALO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Caption Management's HALO Position: Q1 2025 in Review

Caption Management sold out of Halozyme (HALO) in Q1 2025, closing a stake of 13,700 shares — an estimated $655K sold.

Caption Management first reported a position in HALO in Q3 2019 and held it in 5 quarters. The position peaked at $1.56M in Q4 2022. 550 funds tracked by Wall St. Rank hold HALO as of Q1 2025.

Caption Management reported no remaining Halozyme position as of Q1 2025 after selling out during the quarter.
Caption Management sold 13,700 Halozyme shares in Q1 2025, an estimated $655K.
Caption Management first reported a position in Halozyme in Q3 2019 and held it in 5 quarters.
Caption Management's Halozyme position peaked at $1.56M in Q4 2022.
550 funds tracked by Wall St. Rank held Halozyme as of Q1 2025.

Based on Caption Management's 13F filing for Q1 2025, filed 15 May 2025.